BC Innovations | Jul 11, 2013
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Cognitive dysfunction Mitogen-activated protein kinase kinase kinase 11 (MAP3K11; MLK3) Cell culture and mouse studies suggest the MLK3 inhibitor URMC-099 could be used to treat...
BC Innovations | Oct 20, 2011
Distillery Therapeutics

Indication: Musculoskeletal disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Musculoskeletal disease FYVE, RhoGEF and PH domain containing 1 (FGD1); mitogen-activated protein kinase kinase kinase 11 (MAP3K11; MLK3) Studies in...
Items per page:
1 - 2 of 2